BTBD8 and acute kidney injury: Table 2 also compares the discriminatory power of APACHE II and these AKI biomarkers. The AUROC analysis confirmed that serum CysC was the best AKI predictor in the overall CCU population (AUROC 0.895±0.031, p<0.001).